Document Detail

Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia.
MedLine Citation:
PMID:  12044194     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Expression of messenger RNA (mRNA) for the gamma-aminobutyric acid (GABA)-synthesizing enzyme, glutamic acid decarboxylase (GAD), in the prefrontal cortex and the number of GABAergic neurons in the hippocampus are reduced in schizophrenia and bipolar disorder. We tested the hypothesis that the expression of the 2 isoforms, one 65 kd (GAD(65)) and the other 67 kd (GAD(67)), is differentially affected in the hippocampus in schizophrenia and bipolar disorder. METHODS: Hippocampal sections from 15 subjects in 3 groups (control subjects and subjects with schizophrenia and bipolar disorder) were studied using an in situ hybridization protocol with sulfur 35-labeled complementary riboprobes for GAD(65) and GAD(67) mRNA. Emulsion-dipped slides were analyzed for the density of GAD mRNA-positive neurons in 4 sectors of the hippocampus and for the cellular expression level of both GAD mRNAs. RESULTS: The density of GAD(65) and GAD(67) mRNA-positive neurons was decreased by 45% and 43%, respectively, in subjects with bipolar disorder, but only 14% and 4%, respectively, in subjects with schizophrenia. The decreased density of GAD(65) mRNA-positive neurons in subjects with bipolar disorder was significant in sectors CA2/3 and dentate gyrus, and that of GAD(67) mRNA-positive neurons was significant in CA4, but not other hippocampal sectors. Cellular GAD(65) mRNA expression was significantly decreased in subjects with bipolar disorder, particularly in CA4, but not in schizophrenic subjects. Cellular GAD(67) mRNA expression was normal in both groups. CONCLUSION: We have found a region-specific deficit of GAD(65) and GAD(67) mRNA expression in bipolar disorder.
Stephan Heckers; David Stone; John Walsh; John Shick; Pamposh Koul; Francine M Benes
Related Documents :
21970364 - Hypoxia inducible factor 1 (hif1) promotes ldl and vldl uptake through inducing vldlr u...
10549824 - Expression of cytochrome p450scc mrna in the hippocampus of patients with temporal lobe...
15601604 - Heat shock protein 12a shows reduced expression in the prefrontal cortex of subjects wi...
21603974 - The β(2)-subtype of adrenoceptors mediates inhibition of pro-fibrotic events in human l...
23306614 - Cancer upregulated gene 2, a novel oncogene, confers resistance to oncolytic vesicular ...
23115614 - Mrna expression in papillary and anaplastic thyroid carcinoma: molecular anatomy of a k...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Archives of general psychiatry     Volume:  59     ISSN:  0003-990X     ISO Abbreviation:  Arch. Gen. Psychiatry     Publication Date:  2002 Jun 
Date Detail:
Created Date:  2002-06-04     Completed Date:  2002-06-24     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0372435     Medline TA:  Arch Gen Psychiatry     Country:  United States    
Other Details:
Languages:  eng     Pagination:  521-9     Citation Subset:  AIM; IM    
Laboratory of Structural Neuroscience, McLean Hospital, Belmont, MA 02429, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Bipolar Disorder / diagnosis,  enzymology*,  metabolism
Diagnosis, Differential
Glutamate Decarboxylase / metabolism*
Hippocampus / cytology,  enzymology,  metabolism*
Isoenzymes / metabolism
Middle Aged
Neurons / enzymology,  metabolism
Peptide Fragments / metabolism
RNA, Messenger / metabolism
Schizophrenia / diagnosis,  enzymology*,  metabolism
Grant Support
Reg. No./Substance:
0/Isoenzymes; 0/Peptide Fragments; 0/RNA, Messenger; EC Decarboxylase; EC decarboxylase 1

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Brain serotonin 5-HT(1A) receptor binding in schizophrenia measured by positron emission tomography ...
Next Document:  The long-term natural history of the weekly symptomatic status of bipolar I disorder.